Our professionals

En la imagen se puede observar a la Dra. Marta Ferrer Puga, una destacada especialista en Alergología en la Clínica Universidad de Navarra. La Dra. Ferrer cuenta con una amplia experiencia en el diagnóstico y tratamiento de la urticaria crónica y angioedema, ofreciendo soluciones personalizadas y efectivas a sus pacientes.En la Clínica Universidad de Navarra, contamos con un equipo multidisciplinar de profesionales altamente capacitados y tecnología avanzada para brindar atención médica excepcional a nuestros pacientes. Nos enfocamos en proporcionar un servicio personalizado y de alta calidad a quienes confían en nosotros para el manejo de su salud.Si necesita más información sobre nuestros servicios de Alergología, no dude en contactarnos.

Dr. Marta Ferrer Puga

Medical Director of the Clinica Universidad de Navarra.
Head of the Allergy Department
Allergy and Immunology Specialist
Area of Expertise: chronic hives

Works at: Navarre headquarters Madrid headquarters
Be part of: Clínica Universidad de Navarra

Professional career

Graduated in Medicine and Surgery from the University of Zaragoza. She was awarded her doctorate in Medicine by the University of Navarra.

She is an Allergy Specialist at the Clínica Universidad de Navarra. She carried out her postdoctoral training in the Allergy Division at the State University of New York. Afterwards, she worked in the Pulmonary, Allergy and Critical Care Division at the Medical University of South Carolina, where she stayed until she began her work at the Clínica.

She was a Scholar at the Harvard Macy Institute, in the Faculty of Medicine at the University of Harvard.


Throughout her professional career, she has carried out research on chronic hives. Currently, she is focussing her work on the study of the activation and role of basophiles and the response of immunomodulatories. Additionally, in the last few years, she has done research on the design of immunotherapy through nanotechnology. She is the co-author of two international patents on immunotherapy with nanotechnology.

At the moment, she is leading two national multi-centre clinical trials. The first is about the efficiency and safety of Omalizumab (Xolair®) for the treatment of chronic hives (ClinicalTrials.gov Identifier: NCT01713725). And, the second is studying the efficiency and safety of Omalizumab (Xolair®) for the treatment of Cholinergic Hives (Clinicaltrials.gov Identifier: NCT02012387).


  • Hives: chronic and physical
  • Angioedema
  • Allergic skin reactions


As an educator

Titular Professor at the University of Navarra Faculty of Medicine

Head of Medical Education Unit – she put in place the Medical Education Certificate system. She also started several initiatives for educative innovation. Along with her team, they have developed a MOOC (Massive Online Open Course) for hospital teaching, which is the first of its kind in to be created in Spanish.

As a researcher

She has led numerous public research projects (Sanitary Research Fund, Government of Navarra, Ministery of Science and Innovation) (594.751 €) as well as a research project subsidised by the Ramón Areces foundation for the study of the physiopathology, chronic hives and the use of new drugs for immunotherapy with nanotechnology.

Currently she is leading a research project studying the mechanism and role of immunomodulatories in chronic hives.

She has written more than 70 articles in international magazines and 6 book chapters.

She also wrote the book: Why are allergies increasing? Madrid, Editorial Everest, 2005. ISBN: 84-241-8813-6

Imagen de un icono azul con un documento certificado.

Scientific Institutions

  • Chairman of the Allergy Skin Committee of the Spanish Allergy Society.
  • Fellow of the American Academy of Allergy, Asthma and Immunology (AAAAI).
  • Member of the Skin Committee of the AAAAI.
  • Director Board Member of the Skin Allergy Committee of the European Allergy Academy (EAACI).

Latest scientific publications